The Max Planck Institute for Infection Biology (MPIIB) is a non-university research institute of the Max Planck Society located in the heart of Berlin in Berlin-Mitte. It was founded in 1993. [1] Arturo Zychlinsky is currently the Managing Director. [2] The MPIIB is divided into nine research groups, two partner groups and two Emeritus Groups of the founding director Stefan H. E. Kaufmann and the director emeritus Thomas F. Meyer. The department "Regulation in Infection Biology" headed by 2020 Nobel laureate Emmanuelle Charpentier was hived off as an independent research center in May 2018. [3] The Max Planck Unit for the Science of Pathogens is now administratively independent of the Max Planck Institute for Infection Biology. [4] In October 2019, Igor Iatsenko and Matthieu Domenech de Cellès established their research groups at the institute, Mark Cronan started his position as research group leader in March 2020. Silvia Portugal joined the institute in June 2020 as Lise Meitner Group Leader. [5] Two more research groups where added in 2020, Felix M. Key joined in September and Olivia Majer in October, completing the reorganization of the Max Planck Institute for Infection Biology. Simone Reber joined as Max Planck Fellow in 2023 and now heads the research group Quantitative Biology.
The institute also has an International Max Planck Research School for Infectious Diseases and Immunology in Berlin. [17] The IMPRS-IDI is an English language doctoral program with participating faculty from the Free University of Berlin, Humboldt University of Berlin, the Robert Koch Institute, the German Rheumatism Research Center, and the Leibniz Institute for Zoo and Wildlife Research. The IMPRS-IDI, together with five other graduate schools, forms the "ZIBI Graduate School Berlin". IMPRS-IDI's mission is "better understanding of host-pathogen interactions at all levels". Arturo Zychlinsky is the IMPRS-IDI's spokesperson.
A human pathogen is a pathogen that causes disease in humans.
The Max Planck Society for the Advancement of Science is a formally independent non-governmental and non-profit association of German research institutes. Founded in 1911 as the Kaiser Wilhelm Society, it was renamed to the Max Planck Society in 1948 in honor of its former president, theoretical physicist Max Planck. The society is funded by the federal and state governments of Germany.
The Max Planck Institute of Biochemistry is a research institute of the Max Planck Society located in Martinsried, a suburb of Munich. The institute was founded in 1973 by the merger of three formerly independent institutes: the Max Planck Institute of Biochemistry, the Max Planck Institute of Protein and Leather Research, and the Max Planck Institute of Cell Chemistry.
The Max Planck Institute for Gravitational Physics is a Max Planck Institute whose research is aimed at investigating Einstein's theory of relativity and beyond: Mathematics, quantum gravity, astrophysical relativity, and gravitational-wave astronomy. The institute was founded in 1995 and is located in the Potsdam Science Park in Golm, Potsdam and in Hannover where it closely collaborates with the Leibniz University Hannover. Both the Potsdam and the Hannover parts of the institute are organized in three research departments and host a number of independent research groups.
The Max Planck Institute for Biophysical Chemistry, also known as the Karl-Friedrich Bonhoeffer Institute, was a research institute of the Max Planck Society, located in Göttingen, Germany. On January 1, 2022, the institute merged with the Max Planck Institute for Experimental Medicine in Göttingen to form the Max Planck Institute for Multidisciplinary Sciences.
The Max Planck Institute for Molecular Biomedicine was founded on 1 April 2001 in Münster, North Rhine-Westphalia, Germany. It is part of the Max Planck Society. The current managing director is professor Dietmar Vestweber.
The Max Planck Institute of Colloids and Interfaces is located in Potsdam-Golm Science Park in Golm, Potsdam, Germany. It was founded in 1990 as a successor of the Institute for Physical Chemistry and for Organic Chemistry, both in Berlin-Adlershof, and for Polymer Chemistry in Teltow. In 1999, it transferred to newly constructed extension facilities in Golm. It is one of 80 institutes in the Max Planck Society (Max-Planck-Gesellschaft).
The Max Planck Institute for Terrestrial Microbiology is a research institute for terrestrial microbiology in Marburg, Germany. It was founded in 1991 by Rudolf K. Thauer and is one of 80 institutes in the Max Planck Society (Max-Planck-Gesellschaft). Its sister institute is the Max Planck Institute for Marine Microbiology, which was founded a year later in 1992 in Bremen.
The Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany is an interdisciplinary research institute that conducts basic research in modern immunobiology, developmental biology and epigenetics. It was founded in 1961 as the Max Planck Institute of Immunobiology and is one of 86 institutions of the Max Planck Society. Originally named the Max Planck Institute of Immunobiology, it was renamed to its current name in 2010 as it widened its research thrusts to the study of epigenetics.
Avian malaria is a parasitic disease of birds, caused by parasite species belonging to the genera Plasmodium and Hemoproteus. The disease is transmitted by a dipteran vector including mosquitoes in the case of Plasmodium parasites and biting midges for Hemoproteus. The range of symptoms and effects of the parasite on its bird hosts is very wide, from asymptomatic cases to drastic population declines due to the disease, as is the case of the Hawaiian honeycreepers. The diversity of parasites is large, as it is estimated that there are approximately as many parasites as there are species of hosts. As research on human malaria parasites became difficult, Dr. Ross studied avian malaria parasites. Co-speciation and host switching events have contributed to the broad range of hosts that these parasites can infect, causing avian malaria to be a widespread global disease, found everywhere except Antarctica.
The Max Planck Institute (MPI) for Biology of Ageing, founded in 2008, is one of over 80 independent, non-profit-making institutes set up under the umbrella of the Max Planck Society. The overall research aim is to obtain fundamental insights into the aging process and thus to pave the way towards healthier aging in humans. An international research team drawn from almost 40 nations is working to uncover underlying molecular, physiological and evolutionary mechanisms.
Stefan Hugo Ernst Kaufmann is a German immunologist and microbiologist and is one of the highly cited immunologists worldwide for the decade 1990 to 2000. He is amongst the 0.01% most cited scientists of c. 7 million scientists in 22 major scientific fields globally.
The Max Planck Institute for the Physics of Complex systems is one of the 80 institutes of the Max-Planck-Gesellschaft, located in Dresden, Germany.
In biology, a pathogen, in the oldest and broadest sense, is any organism or agent that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.
Emmanuelle Marie Charpentier is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing". This was the first science Nobel Prize ever won by two women only.
Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.
Hedda Wardemann is an immunologist and Professor in the Division of B cell immunology at the German Cancer Research Center in Heidelberg, Germany.
Regine Kahmann is a German microbiologist and was Director at the Max Planck Institute for Terrestrial Microbiology in Marburg from 2000 to 2019. She was made a Foreign Member of the Royal Society (ForMRS) in 2020.
Arturo Zychlinsky is a biologist and since 2001 director at the Max Planck Institute for Infection Biology. His research focuses on Neutrophil Extracellular Traps (NETs) which he discovered together with Volker Brinkmann, and the immune function of chromatin.
Jean Langhorne is a British biologist who is a group leader at the Francis Crick Institute. Langhorne has studied immune responses to malaria and Plasmodium falciparum. She was awarded the 2016 EMBO-BioMalPar Lifetime Achievement Award for her work on malaria immunology. She is Associate Editor of PLOS Pathogens and on the Advisory Board of Trends in Immunology.